Gen-Probe to Webcast Two Upcoming Investor Presentations
October 30 2009 - 4:01PM
PR Newswire (US)
- Oppenheimer 20th Annual Healthcare Conference on November 3 - -
Lazard Capital Markets 6th Annual Healthcare Conference on November
18 - SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- Gen-Probe
Incorporated (NASDAQ:GPRO) announced today that the Company will
present at the Oppenheimer 20th Annual Healthcare Conference in New
York on November 3, 2009 at approximately 2:10 p.m. Eastern time,
and at the Lazard Capital Markets 6th Annual Healthcare Conference
in New York on November 18, 2009 at approximately 9 a.m. Eastern
time. The presentations are scheduled to be webcast live and may be
accessed through a link on the investors section of Gen-Probe's
website at http://www.gen-probe.com/. The webcasts will be
available for 30 days following the events. About Gen-Probe
Gen-Probe Incorporated is a global leader in the development,
manufacture and marketing of rapid, accurate and cost-effective
nucleic acid tests (NATs) that are used primarily to diagnose human
diseases and screen donated human blood. Gen-Probe has
approximately 25 years of NAT expertise, and received the 2004
National Medal of Technology, America's highest honor for
technological innovation, for developing NAT assays for blood
screening. Gen-Probe is headquartered in San Diego and employs
approximately 1,200 people. For more information, go to
http://www.gen-probe.com/. Caution Regarding Forward-Looking
Statements Any statements in this press release about our
expectations, beliefs, plans, objectives, assumptions or future
events or performance are not historical facts and are
forward-looking statements. Forward-looking statements are not
guarantees of performance. They involve known and unknown risks,
uncertainties and assumptions that may cause actual results, levels
of activity, performance or achievements to differ materially from
those expressed or implied. For information about risks and
uncertainties we face and a discussion of our financial statements
and footnotes, see documents we have filed with the SEC, including
the Form 10-Q for the period ended June 30, 2009, and all
subsequent periodic filings made with the SEC. We assume no
obligation and expressly disclaim any duty to update any
forward-looking statement to reflect events or circumstances after
the date of this press release or to reflect the occurrence of
unanticipated events. Contact: Paula Izidoro Investor Relations
858-410-8904 DATASOURCE: Gen-Probe Incorporated CONTACT: Paula
Izidoro, Investor Relations of Gen-Probe Incorporated,
+1-858-410-8904 Web Site: http://www.gen-probe.com/
Copyright
GoPro (NASDAQ:GPRO)
Historical Stock Chart
From Jun 2024 to Jul 2024
GoPro (NASDAQ:GPRO)
Historical Stock Chart
From Jul 2023 to Jul 2024